MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Modeling disease progression in spinocerebellar ataxias

    J. Faber, E. Georgii, T. Klockgether, T. Ashizawa, K. Sheng-Han, H. Jacobi, M. Piraud (Bonn, Germany)

    Objective: In the context of emerging gene-targeted therapies for polyglutamine spinocerebellar ataxias (SCAs), identifying predictive clinical markers of disease progression is becoming increasingly relevant. We…
  • 2026 International Congress

    Genetic modifiers of the clinical phenotype in Spinocerebellar Ataxia type 2. 25 years of candidate genes studies and the forthcoming GWAS era

    L. Almaguer-Mederos (London, United Kingdom)

    Objective: To provide a critical review the state of the art on the search for modifier genes for disease severity of SCA2. Background: Spinocerebellar ataxia…
  • 2026 International Congress

    Temporal Ordering of Biomarker Abnormality Events Leading to Cognitive Impairment in Parkinson’s Disease: A Disease Event-Based Model Analysis of the PPMI Cohort

    A. Negida (Richmond, USA)

    Objective: To estimate the temporal ordering of multimodal biomarker abnormality events leading to cognitive impairment in PD using a Disease Event-Based Model (DEBM), incorporating clinical,…
  • 2026 International Congress

    The Impact of Insomnia and Sleep Fragmentation on Quality of Life and Neuropsychiatric Outcomes in Restless Legs Syndrome

    A. Kumar, P. Mishra (Delhi, India)

    Objective: To quantify the prevalence of insomnia, sleep architecture disruption, and their cascading impacts on emotional well-being and overall quality of life in patients with…
  • 2026 International Congress

    Clinical Characteristics and Functional Impact of Tremor in Patients with Multiple Sclerosis in Nepal: A Cross-Sectional Observational Study

    AYU. Chandra, AVI. Chandra (Kathmandu, Nepal)

    Objective: To describe the clinical characteristics of tremor in multiple sclerosis (MS) patients in Nepal and assess its functional impact on daily living. To describe…
  • 2026 International Congress

    Diet Quality and Nutrient Intake in Parkinson’s Disease: A Multicenter Study in Egypt

    E. Abed (Cairo, Egypt)

    Objective: To compare diet quality and nutrient intake between PD patients and controls and examine associations with PD clinical features. Background: Parkinson’s disease (PD) is…
  • 2026 International Congress

    The GLP-1 Agonist Paradox in Parkinson’s Disease: A Comparative Analysis of Lixisenatide and Exenatide Phase III Trial Outcomes and Neuroprotective Mechanisms

    F. Al-Zaidi (Almaty, Kazakhstan)

    Objective: To assess the pharmacological and methodological factors underlying the "GLP-1 paradox" by comparing the outcomes of lixisenatide and exenatide, with an emphasis on kinetics,…
  • 2026 International Congress

    Effect of clonazepam on restless legs syndrome in a multiparous pregnant woman

    S. Telarović, L. čondić Jurjević (Zagreb, Croatia)

    Objective: To report a case of a multiparous pregnant woman with severe restless legs syndrome (RLS) in her seventh pregnancy who was treated with a…
  • 2026 International Congress

    Sex Differences for Primary Psychiatric Diagnoses and Associated Care Outcomes in Dementia with Lewy Bodies using Epic Cosmos

    S. Holden, E. Bayram, S. Aslam, T. Carlisle, M. Fullard, B. Bettcher, V. Pelak (Aurora, USA)

    Objective: Assess sex differences for documented primary psychiatric diagnoses in people with dementia with Lewy bodies (DLB) and their associations with care outcomes (hospitalization, specialty…
  • 2026 International Congress

    Modulation of Excitatory/Inhibitory Neurotransmission via Targeting GABAA-Gephyrin Signaling: Integrated In-Silico, In-Vitro, and In-Vivo Evidence in Parkinson’s Disease Models

    S. Chib (Bathinda, India)

    Objective: To evaluate the neuroprotective potential of wogonin in modulating excitatory–inhibitory neurotransmission via GABAA receptor and gephyrin signaling in rat models of Parkinson’s disease (PD).…
  • « Previous Page
  • 1
  • …
  • 192
  • 193
  • 194
  • 195
  • 196
  • …
  • 208
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley